You are here: Industry Insights > NICE

News List

NICE issues draft guidance, finding negative opinion for volanesorsen europeanpharmaceuticalreview
January 06, 2020
Waylivra (volanesorsen) has not been recommended for treatment of familial chylomicronaemia syndrome, according to draft guidance from NICE.
Treatment for hyperkalaemia recommended by NICE for NHS europeanpharmaceuticalreview
December 19, 2019
NICE has recommended patients in England have access to a new treatment option for treating hyperkalaemia (raised serum potassium levels) in adults.
NICE approves new tablet formulation for olaparib drug europeanpharmaceuticalreview
December 10, 2019
The UK NICE has extended its approval for olaparib, updating its formulation from eight capsules twice a day to two tablets twice daily.
Erenumab migraine drug fails to meet NICE recommendation standards europeanpharmaceuticalreview
September 27, 2019
NICE has announced that it will not be recommending erenumab, an injectable migraine treatment, due to issues with cost and its long-term effectiveness.
NICE recommends Takeda’s Takhzyro in hereditary angioedema pharmaceutical-technology
September 25, 2019
The UK’s National Institute for Health and Clinical Excellence (NICE) has recommended the use of subcutaneous injection of Takeda’s Takhzyro (lanadelumab) to prevent recurrent attacks ...
Hereditary angioedema treatment recommended by NICE europeanpharmaceuticalreview
September 20, 2019
Lanadelumab, a preventive treatment for hereditary angioedema, has been recommended as a cost-effective use of NHS resources.
NICE recommends voretigene neparvovec for use on NHS europeanpharmaceuticalreview
September 05, 2019
The voretigene neparvovec gene therapy treatment has been highlighted in draft guidance by NICE for availability on the NHS.
NICE to work with GW Pharma on cannabidiol evaluation europeanpharmaceuticalreview
August 29, 2019
NICE and GW Pharma will work together to address the issues highlighted in its evaluation of cannabidiol for treating two types of epilepsy.
Dillon, who shaped NICE into an influential gatekeeper, ready to exit CEO post fiercepharma
August 25, 2019
Twenty years after its founding, England’s National Institute for Health and Care Excellence (NICE) has established itself as perhaps the world’s preeminent drug cost watchdog. Now, the only leader it has ever known will step down from his post.
NICE releases draft guidance for using cannabis-based medicinal products europeanpharmaceuticalreview
August 12, 2019
The NICE and NHS have announced their draft recommendations for the prescribed use of cannabis-based treatments.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 41 42 Next page